- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期的强势行情可能结束，投资者及时短线卖出、离场观望为宜。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有147家主力机构披露2025-12-31报告期持股数据，持仓量总计1.72亿股，占流通A股45.92%
- 波段诊断：
-
技术面诊股
诊断结果：5.0技术面打败了76%的股票
技术面评分前10的股票
近期的平均成本为20.08元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为20.08元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"20.08","date":1782377957,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑赢大盘，明显跑赢行业平均水平。
[{"date":"2026.06.26","stock":"-5.94","trade":"-4.86","ind":"-2.26"},{"date":"2026.06.25","stock":"2.05","trade":"-1.35","ind":"0.23"},{"date":"2026.06.24","stock":"6.02","trade":"-0.89","ind":"0.11"},{"date":"2026.06.23","stock":"5.82","trade":"3.68","ind":"-1.37"},{"date":"2026.06.22","stock":"-2.31","trade":"0.07","ind":"1.78"},{"date":"2026.06.18","stock":"4.48","trade":"0.66","ind":"-0.43"},{"date":"2026.06.17","stock":"-0.83","trade":"-1.16","ind":"0.40"},{"date":"2026.06.16","stock":"0.78","trade":"-0.99","ind":"-0.11"},{"date":"2026.06.15","stock":"-2.72","trade":"0.15","ind":"1.61"},{"date":"2026.06.12","stock":"4.08","trade":"2.07","ind":"1.12"},{"date":"2026.06.11","stock":"-1.67","trade":"-1.24","ind":"-0.16"},{"date":"2026.06.10","stock":"-1.05","trade":"-0.14","ind":"-0.42"},{"date":"2026.06.09","stock":"-0.17","trade":"0.45","ind":"1.28"},{"date":"2026.06.08","stock":"-3.40","trade":"-2.49","ind":"-1.70"},{"date":"2026.06.05","stock":"-1.10","trade":"0.25","ind":"-0.74"},{"date":"2026.06.04","stock":"-1.60","trade":"-1.80","ind":"-0.64"},{"date":"2026.06.03","stock":"0.78","trade":"-1.10","ind":"0.22"},{"date":"2026.06.02","stock":"-1.79","trade":"-2.06","ind":"0.43"},{"date":"2026.06.01","stock":"-2.40","trade":"0.40","ind":"-0.27"},{"date":"2026.05.29","stock":"-3.80","trade":"0.36","ind":"-0.73"},{"date":"2026.05.28","stock":"-2.81","trade":"-0.71","ind":"0.12"}]
前沿生物,上证指数,化学制药指数
压力支撑
该股压力位为20.15元，支撑位为19.20元。
[{"text":"\u538b\u529b\u4f4d","value":"20.15","date":1782403200,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"19.20","date":1782403200,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：3.5资金面打败了46%的股票
主力控盘前10的股票
行业资金
化学制药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：06月26日 20:31
| 机构今日流向(万元) | -2964.66 | 机构5日流向(万元) | -3396.69 |
| 机构10日流向(万元) | -4112.80 | 机构20日流向(万元) | -10202.10 |
机构持仓
2025-12-31 与 2025-06-30 相比，主力机构持仓量增加2952.26万股，其中基金净减仓16家，主力净增仓77家，请投资者中长期谨慎为宜。
截止2025-12-31，共147家主力机构（基金142家，一般法人5家），持仓量总计17201.86万股，占流通A股45.92%
其中，基金持仓与2025-06-30相比：
增仓：2家 ，增持 472.67万股
减仓：18家 ，减持 89.61万股
新出现在主力名单中：122家 ，持有5264.99万股
从主力名单中消失：45家 ，原持有2695.79万股
其中，基金持仓与2025-06-30相比：
增仓：2家 ，增持 472.67万股
减仓：18家 ，减持 89.61万股
新出现在主力名单中：122家 ，持有5264.99万股
从主力名单中消失：45家 ，原持有2695.79万股
消息面诊股
诊断结果：5.2消息面打败了77%的股票
今日有利好新闻的公司
近期该股消息面总体多空平衡，没有较强的利好或利空趋势。
更多>>个股资讯
- 前沿生物：6月25日获融资买入4614.23万元
2026-06-26 - 前沿生物：6月24日获融资买入5781.19万元
2026-06-25 - 前沿生物连续2日融资买入额增长率超50%，多头加速
2026-06-25 - 前沿生物：6月23日获融资买入3045.22万元
2026-06-24 - 群益证券：首次覆盖前沿生物给予增持评级，目标价22
2026-06-23 - 抗肿瘤药行业现状与发展趋势分析(2026年)
2026-06-23 - 前沿生物：6月22日获融资买入1984.60万元
2026-06-23 - 前沿生物：6月18日获融资买入2157.82万元
2026-06-19 - 创新药板块短线拉升，华森制药涨停
2026-06-18 - 前沿生物：6月17日获融资买入1306.00万元
2026-06-18
消息列表
| 一般消息 | 募资投向 | 2026-06-05 | |
| 一般消息 | 股东大会 | 年度股东大会 | 2026-04-25 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-04-25 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-25 |
| 一般消息 | 重大事项 | 关联交易 | 2026-04-25 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-01-31 |
| 一般消息 | 高管变动 | 取消监事会 | 2025-11-19 |
| 一般消息 | 分红转增 | 不分配不转增 | 2025-08-30 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 2条 | 2条 | 0条 |
行业面诊股
诊断结果：1.8行业面打败了29%的股票
化学制药行业最新资金流向
近10日来该行业走势不明显，明显跑输大盘。
行业走势
近10日来该行业走势不明显，明显跑输大盘。
[{"date":"2026.06.26","price":"-2.26","value":"-4.86"},{"date":"2026.06.25","price":"0.23","value":"-1.35"},{"date":"2026.06.24","price":"0.11","value":"-0.89"},{"date":"2026.06.23","price":"-1.37","value":"3.68"},{"date":"2026.06.22","price":"1.78","value":"0.07"},{"date":"2026.06.18","price":"-0.43","value":"0.66"},{"date":"2026.06.17","price":"0.40","value":"-1.16"},{"date":"2026.06.16","price":"-0.11","value":"-0.99"},{"date":"2026.06.15","price":"1.61","value":"0.15"},{"date":"2026.06.12","price":"1.12","value":"2.07"},{"date":"2026.06.11","price":"-0.16","value":"-1.24"},{"date":"2026.06.10","price":"-0.42","value":"-0.14"},{"date":"2026.06.09","price":"1.28","value":"0.45"},{"date":"2026.06.08","price":"-1.70","value":"-2.49"},{"date":"2026.06.05","price":"-0.74","value":"0.25"},{"date":"2026.06.04","price":"-0.64","value":"-1.80"},{"date":"2026.06.03","price":"0.22","value":"-1.10"},{"date":"2026.06.02","price":"0.43","value":"-2.06"},{"date":"2026.06.01","price":"-0.27","value":"0.40"},{"date":"2026.05.29","price":"-0.73","value":"0.36"},{"date":"2026.05.28","price":"0.12","value":"-0.71"}]
上证指数,化学制药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 花园生物 | 80.80% | 35.93% | 5.1分 |
| 2 | 富祥股份 | 33.29% | 6.06% | 5.8分 |
| 3 | 灵康药业 | 32.85% | 14.23% | 6.4分 |
| 4 | 百利天恒 | 19.58% | 14.45% | 5.6分 |
| 5 | 贝达药业 | 19.29% | 5.27% | 5.9分 |
| 6 | 海欣股份 | 10.69% | 9.45% | 4.6分 |
| 8 | 海思科 | 9.99% | 13.22% | 5.6分 |
| 10 | 艾力斯 | 6.95% | 9.96% | 5.8分 |
| 12 | 纳微科技 | 5.16% | -1.18% | 5.8分 |
| 14 | 通化金马 | 3.28% | -1.88% | 5.3分 |
| 16 | 海辰药业 | 2.04% | -14.35% | 4.8分 |
| 18 | 恒瑞医药 | 1.40% | 0.52% | 5.7分 |
| 20 | 华特达因 | 1.05% | -0.22% | 5.0分 |
| 22 | 海正药业 | 0.00% | 0.81% | 5.5分 |
| 24 | 丽珠集团 | -0.49% | -2.97% | 4.9分 |
| 26 | - | -0.64% | 1.97% | 分 |
| 28 | - | -1.15% | -0.83% | 分 |
| 30 | 司太立 | -1.91% | 7.67% | 5.6分 |
| 32 | 兴齐眼药 | -2.13% | 5.98% | 5.0分 |
| 34 | 石药创新 | -2.46% | 6.05% | 4.4分 |
| 36 | 圣诺生物 | -2.68% | -0.55% | 5.2分 |
| 38 | 国邦医药 | -2.84% | -3.42% | 4.7分 |
| 40 | 普洛药业 | -3.39% | -2.50% | 5.0分 |
| 42 | 健康元 | -4.03% | -3.13% | 4.2分 |
| 44 | 民生健康 | -4.97% | -1.47% | 5.0分 |
| 46 | 威尔药业 | -5.00% | -2.23% | 5.0分 |
| 48 | 复旦张江 | -5.46% | -3.08% | 4.9分 |
| 50 | 华北制药 | -5.62% | -4.11% | 4.6分 |
| 52 | ST惠程 | -5.70% | -1.36% | 4.8分 |
| 54 | 华邦健康 | -5.90% | -3.16% | 4.0分 |
| 56 | - | -6.27% | -4.83% | 分 |
| 58 | ST能特 | -6.33% | -4.17% | 4.5分 |
| 60 | 新华制药 | -6.58% | 3.35% | 4.3分 |
| 62 | 键凯科技 | -6.77% | 2.57% | 5.4分 |
| 64 | 信立泰 | -7.34% | -0.76% | 5.0分 |
| 66 | 金城医药 | -7.76% | -5.13% | 5.2分 |
| 68 | 同和药业 | -8.16% | -3.96% | 4.4分 |
| 70 | 德展健康 | -8.56% | 0.67% | 4.5分 |
| 72 | 金石亚药 | -8.71% | 0.22% | 4.4分 |
| 74 | 北大医药 | -9.25% | -8.21% | 4.3分 |
| 76 | 恩华药业 | -9.39% | -2.46% | 4.3分 |
| 78 | 海普瑞 | -9.80% | -1.37% | 4.4分 |
| 80 | 浙江医药 | -10.25% | -2.00% | 4.2分 |
| 82 | 哈药股份 | -10.40% | -4.87% | 3.9分 |
| 84 | - | -10.79% | -9.45% | 分 |
| 86 | - | -10.97% | -2.33% | 分 |
| 88 | 盟科药业 | -11.18% | -9.07% | 4.4分 |
| 90 | 凯因科技 | -11.71% | -7.23% | 4.5分 |
| 92 | 华仁药业 | -11.79% | -4.63% | 4.3分 |
| 94 | 海森药业 | -12.04% | -9.70% | 3.6分 |
| 96 | 神奇制药 | -12.18% | -5.50% | 4.9分 |
| 98 | 鲁抗医药 | -12.45% | -3.94% | 4.0分 |
| 100 | 津药药业 | -12.70% | -3.30% | 4.3分 |
| 102 | 北陆药业 | -12.89% | -5.61% | 4.3分 |
| 104 | 健友股份 | -13.20% | -4.34% | 5.0分 |
| 106 | 润都股份 | -13.94% | -4.70% | 4.3分 |
| 108 | 易明医药 | -14.67% | -9.09% | 4.5分 |
| 110 | 康芝药业 | -14.95% | -6.94% | 3.5分 |
| 112 | 富士莱 | -15.15% | -5.24% | 3.7分 |
| 114 | 益方生物 | -15.56% | -7.16% | 4.2分 |
| 116 | 华纳药厂 | -15.62% | -9.47% | 4.0分 |
| 118 | 宣泰医药 | -15.68% | -4.10% | 4.4分 |
| 120 | 拓新药业 | -16.18% | -8.39% | 3.4分 |
| 122 | 本立科技 | -16.46% | -4.33% | 4.5分 |
| 124 | 海创药业 | -16.68% | -7.00% | 3.9分 |
| 126 | 亚太药业 | -17.29% | -2.98% | 3.6分 |
| 128 | 汇宇制药 | -17.49% | -9.38% | 4.9分 |
| 130 | 舒泰神 | -17.76% | -5.37% | 3.7分 |
| 132 | ST天圣 | -18.12% | -8.32% | 3.5分 |
| 134 | 苑东生物 | -18.52% | -7.73% | 4.6分 |
| 136 | 翰宇药业 | -18.81% | -10.14% | 4.3分 |
| 138 | 莎普爱思 | -18.94% | -6.68% | 4.1分 |
| 140 | 一品红 | -19.99% | -2.72% | 3.9分 |
| 142 | ST复华 | -21.18% | -13.21% | 3.5分 |
| 144 | 奥翔药业 | -21.50% | -4.68% | 4.0分 |
| 146 | 多瑞医药 | -23.24% | -11.77% | 3.8分 |
| 148 | 上海谊众 | -24.67% | -4.75% | 4.5分 |
| 150 | 昂利康 | -26.31% | -8.18% | 3.4分 |
| 152 | 美诺华 | -29.49% | -15.40% | 3.3分 |
| 154 | 悦康药业 | -31.24% | -6.15% | 4.0分 |
| 156 | 迪哲医药 | -32.71% | -3.87% | 4.8分 |
| 158 | 常山药业 | -41.45% | -11.76% | 3.8分 |
行业评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 暂无相关评级 |
更多>>行业资讯
- 2012-02-17青岛：加快向“世界强港”转型新增万吨级泊位24个
- 2012-02-17江苏港口发展“四稳四进”
- 2012-02-17今年河北省重点打造综合性港口群
- 2012-02-16招商轮船：非公开发行A股股票申请获得中国证券监督管理委员会核准
- 2012-02-16泉州市今年将冲刺“亿吨大港”
- 2012-02-16大连市集装箱运输生产“逆市飘红”
- 2012-02-16江苏港口发展“四稳四进”
- 2012-02-16连云港港：绿色生态大港正向我们走来
- 2012-02-15靖江今年港口建设预投28亿元 完成港口货物吞吐量8000万吨
- 2012-02-15舟山“大港口”建设撬动群岛新区大盘
基本面诊股
[ 截止日期：2026-03-31 ]公司经营
盈利能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 3/218 ， 7/218。
[{"date":"2026-03-31","value":"22.91","vol":"0.43"},{"date":"2025-12-31","value":"-26.56","vol":"-2.03"},{"date":"2025-09-30","value":"-15.06","vol":"1.53"},{"date":"2025-06-30","value":"-8.91","vol":"1.24"},{"date":"2025-03-31","value":"-3.94","vol":"-0.13"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
22.91 | -26.56 | -15.06 | -8.91 | -3.94 |
| 行业(%) | 0.43 | -2.03 | 1.53 | 1.24 | -0.13 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"94.01","vol":"50.72"},{"date":"2025-12-31","value":"33.22","vol":"49.72"},{"date":"2025-09-30","value":"34.84","vol":"49.60"},{"date":"2025-06-30","value":"30.99","vol":"49.57"},{"date":"2025-03-31","value":"32.47","vol":"49.06"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
94.01 | 33.22 | 34.84 | 30.99 | 32.47 |
| 行业(%) | 50.72 | 49.72 | 49.60 | 49.57 | 49.06 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 2/218 ， 8/218。
[{"date":"2026-03-31","value":"948.89","vol":"25.51"},{"date":"2025-12-31","value":"-4.70","vol":"38.97"},{"date":"2025-09-30","value":"12.80","vol":"141.63"},{"date":"2025-06-30","value":"14.85","vol":"78.56"},{"date":"2025-03-31","value":"14.93","vol":"0.01"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
948.89 | -4.70 | 12.80 | 14.85 | 14.93 |
| 行业(%) | 25.51 | 38.97 | 141.63 | 78.56 | 0.01 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"615.38","vol":"47.13"},{"date":"2025-12-31","value":"-33.11","vol":"-26.11"},{"date":"2025-09-30","value":"17.39","vol":"-2.93"},{"date":"2025-06-30","value":"39.33","vol":"59.61"},{"date":"2025-03-31","value":"20.80","vol":"-10.40"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
615.38 | -33.11 | 17.39 | 39.33 | 20.80 |
| 行业(%) | 47.13 | -26.11 | -2.93 | 59.61 | -10.40 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 13/218 ， 131/218。
[{"date":"2026-03-31","value":"0.17","vol":"0.10"},{"date":"2025-12-31","value":"0.07","vol":"0.41"},{"date":"2025-09-30","value":"0.06","vol":"0.31"},{"date":"2025-06-30","value":"0.03","vol":"0.21"},{"date":"2025-03-31","value":"0.02","vol":"0.10"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.17 | 0.07 | 0.06 | 0.03 | 0.02 |
| 行业(次) | 0.10 | 0.41 | 0.31 | 0.21 | 0.10 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.25","vol":"0.65"},{"date":"2025-12-31","value":"1.53","vol":"2.58"},{"date":"2025-09-30","value":"1.50","vol":"1.93"},{"date":"2025-06-30","value":"0.78","vol":"1.29"},{"date":"2025-03-31","value":"0.44","vol":"0.66"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.25 | 1.53 | 1.50 | 0.78 | 0.44 |
| 行业(次) | 0.65 | 2.58 | 1.93 | 1.29 | 0.66 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：数据暂时不全，请后续关注
[{"date":"2026-03-31","value":"73.33","vol":"-2.81"},{"date":"2025-12-31","value":"-373.76","vol":"16.49"},{"date":"2025-09-30","value":"-119.73","vol":"4.26"},{"date":"2025-06-30","value":"-163.50","vol":"2.95"},{"date":"2025-03-31","value":"-171.81","vol":"-26.33"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 73.33 | -373.76 | -119.73 | -163.50 | -171.81 |
| 行业 | -2.81 | 16.49 | 4.26 | 2.95 | -26.33 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.68","vol":"1.60"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"1.15","vol":"1.71"},{"date":"2025-03-31","value":"","vol":"0.00"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | - | 0.68 | - | 1.15 | - |
| 行业 | 0.00 | 1.60 | 0.00 | 1.71 | 0.00 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：较强，高于行业平均，建议加强关注，两项指标的行业排名分别为 100/218 ， 100/218。
[{"date":"2026-03-31","value":"3.54","vol":"3.57"},{"date":"2025-12-31","value":"2.45","vol":"3.31"},{"date":"2025-09-30","value":"2.70","vol":"3.48"},{"date":"2025-06-30","value":"2.88","vol":"3.66"},{"date":"2025-03-31","value":"2.72","vol":"3.57"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 流动比率 |
3.54 | 2.45 | 2.70 | 2.88 | 2.72 |
| 行业 | 3.57 | 3.31 | 3.48 | 3.66 | 3.57 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"2.49","vol":"2.93"},{"date":"2025-12-31","value":"2.21","vol":"2.69"},{"date":"2025-09-30","value":"2.50","vol":"2.73"},{"date":"2025-06-30","value":"2.65","vol":"2.88"},{"date":"2025-03-31","value":"2.44","vol":"2.80"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 速动比率 |
2.49 | 2.21 | 2.50 | 2.65 | 2.44 |
| 行业 | 2.93 | 2.69 | 2.73 | 2.88 | 2.80 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：一般，低于行业平均，建议投资者谨慎，两项指标的行业排名分别为 37/218 ， 54/218。
[{"date":"2026-03-31","value":"40.11","vol":"33.54"},{"date":"2025-12-31","value":"44.44","vol":"34.70"},{"date":"2025-09-30","value":"40.06","vol":"34.06"},{"date":"2025-06-30","value":"37.23","vol":"34.12"},{"date":"2025-03-31","value":"36.35","vol":"34.09"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
40.11 | 44.44 | 40.06 | 37.23 | 36.35 |
| 行业(%) | 33.54 | 34.70 | 34.06 | 34.12 | 34.09 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-03-31","value":"0.67","vol":"9.77"},{"date":"2025-12-31","value":"0.80","vol":"1.76"},{"date":"2025-09-30","value":"0.67","vol":"1.19"},{"date":"2025-06-30","value":"0.59","vol":"0.87"},{"date":"2025-03-31","value":"0.57","vol":"1.44"}]
| 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.67 | 0.80 | 0.67 | 0.59 | 0.57 |
| 行业(%) | 9.77 | 1.76 | 1.19 | 0.87 | 1.44 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构评级
最近60个交易日，机构评级以买入为主，认为该股票非常值得关注。
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 群益证券(香港) | 2026-06-23 | 增持 | |
| 长江证券 | 2026-05-19 | 买入 | |
| 国泰海通证券 | 2026-05-12 | 买入 | |
| 国联民生 | 2026-04-30 | 买入 | |
| 开源证券 | 2026-04-28 | 买入 | |
| 湘财证券 | 2026-03-28 | 买入 |
机构预测
机构预测该股2026年每股收益与前一年相同，长期投资价值一般。
[{"date":"2022","yellowRectValue":"-3.57","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"-3.29","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-2.01","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-2.68","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"-0.30","blueLineValue":"-0.08","type":"YC"}]